Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2025-10-23

FDA Approved: OLANZAPINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for olanzapine from Aurobindo Pharma Limited. This action typically involves labeling changes for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

SUPPL AP for OLANZAPINE (OLANZAPINE)